HG

Huiping Guan

SU Sugen: 7 patents #24 of 125Top 20%
PC Pharmacia & Upjohn Company: 3 patents #145 of 713Top 25%
BB Birdie Biopharmaceuticals: 2 patents #2 of 3Top 70%
SP Syros Pharmaceuticals: 1 patents #39 of 53Top 75%
AA Astrazeneca Ab: 1 patents #1,022 of 1,971Top 55%
CC Cisen Pharmaceutical Co.: 1 patents #2 of 36Top 6%
AP Agouron Pharmaceuticals: 1 patents #185 of 327Top 60%
📍 Shanghai, MA: #39 of 131 inventorsTop 30%
Overall (All Time): #193,514 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
11834448 2-amino-quinoline derivatives Lixin Li 2023-12-05
11773078 Furin inhibitors Jeffrey Michael Axten, Mui Cheung, Michael P. Demartino, Yan Hu, Aaron Bayne Miller +4 more 2023-10-03
11053240 2-amino-quinoline derivatives Lixin Li 2021-07-06
11040981 Pyrrolotriazine compounds and methods of inhibiting TAM kinases David Moebius, Jason J. Marineau, Yi Zhang, Claudio Edmundo Chuaqui, Goran Malojcic +6 more 2021-06-22
10709695 Compounds as rearranged during transfection (RET) inhibitors Michael P. Demartino 2020-07-14
10294236 Compounds as rearranged during transfection (RET) inhibitors Mui Cheung, Michael P. Demartino, Hilary Schenck Eidam, Donghui Qin, Chengde Wu +4 more 2019-05-21
10292975 Compounds as rearranged during transfection (RET) inhibitors Michael P. Demartino 2019-05-21
10111866 Compounds as rearranged during transfection (RET) inhibitors Michael P. Demartino 2018-10-30
9918974 Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors Michael P. Demartino 2018-03-20
9879021 Compounds as rearranged during transfection (RET) inhibitors Mui Cheung, Michael P. Demartino, Hilary Schenck Eidam, Donghui Qin, Chengde Wu +4 more 2018-01-30
9868737 Pyridino[1,2-A]pyrimidone analogue used as MTOR/P13K inhibitor Chengde Wu, Tao Yu, Lei Huang, Dongling Hao, Bo Gao +3 more 2018-01-16
9035063 Compounds as rearranged during transfection (RET) inhibitors Hilary Schenck Eidam, Chengde Wu, Mui Cheung 2015-05-19
8937071 Compounds as rearranged during transfection (RET) inhibitors Hilary Schenck Eidam, Kaushik Raha, Zhen Gong, Chengde Wu, Haiying Yang +3 more 2015-01-20
8088784 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer Xiaomei Feng, Ying-Chian Kang, Stephanos Ioannidis, Bo Peng, Mei Su +3 more 2012-01-03
7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors Congxin Liang, Li-Qiang Sun, Peng Cho Tang, Chung Chen Wei, Tomas Vojkovsky +3 more 2009-09-01
7256189 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors Congxin Liang, Li-Qiang Sun, Peng Cho Tang, Chung Chen Wei, Tomas Vojkovsky +3 more 2007-08-14
7186832 Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors Connie Sun, Congxin Liang, Ping Huang, G. Davis Harris, Jr. 2007-03-06
7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors Congxin Liang, Li-Qiang Sun, Peng Cho Tang, Chung Chen Wei, Tomas Vojkovsky +3 more 2007-02-20
7157460 Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors Connie Sun, Congxin Liang, Ping Huang, G. Davis Harris, Jr. 2007-01-02
6777417 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors Congxin Liang, Peng Cho Tang, Robert A. Blake 2004-08-17
6653308 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors Congxin Liang, Li-Qiang Sun, Peng Cho Tang, Chung Chen Wei, Tomas Vojkovsky +3 more 2003-11-25
6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors Matthew N. Mattson, Tomas Vojkovsky, Congxin Liang, Peng Cho Tang 2003-11-04